These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 33542898)

  • 21. Extended Real-World Observation of Patients Treated with Sorafenib for Radioactive Iodine-Refractory Differentiated Thyroid Carcinoma and Impact of Lenvatinib Salvage Treatment: A Korean Multicenter Study.
    Oh HS; Shin DY; Kim M; Park SY; Kim TH; Kim BH; Kim EY; Kim WB; Chung JH; Shong YK; Lim DJ; Kim WG
    Thyroid; 2019 Dec; 29(12):1804-1810. PubMed ID: 31592739
    [No Abstract]   [Full Text] [Related]  

  • 22. Comparative analysis of the prognosis of external beam radiation therapy (EBRT) and EBRT plus brachytherapy for glioblastoma multiforme: a SEER population-based study.
    Yang K; Ma Y; Chen G; Zeng S; Guo T; Yang Z
    Radiat Oncol; 2022 Oct; 17(1):174. PubMed ID: 36307810
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Overall survival according to immunotherapy and radiation treatment for metastatic non-small-cell lung cancer: a National Cancer Database analysis.
    Foster CC; Sher DJ; Rusthoven CG; Verma V; Spiotto MT; Weichselbaum RR; Koshy M
    Radiat Oncol; 2019 Jan; 14(1):18. PubMed ID: 30691492
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Locoregional disease control after external beam radiotherapy in 91 patients with differentiated thyroid carcinoma and pT4 tumor stage - a single institution experience.
    Besic N; Dremelj M; Pilko G
    Radiol Oncol; 2018 Sep; 52(4):453-460. PubMed ID: 30244234
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Adjuvant external-beam radiotherapy in patients with high-risk well-differentiated thyroid cancer.
    Chen PV; Osborne R; Ahn E; Avitia S; Juillard G
    Ear Nose Throat J; 2009 Jul; 88(7):E01. PubMed ID: 19623515
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Optimisation of chemotherapy and radiotherapy for untreated Hodgkin lymphoma patients with respect to second malignant neoplasms, overall and progression-free survival: individual participant data analysis.
    Franklin J; Eichenauer DA; Becker I; Monsef I; Engert A
    Cochrane Database Syst Rev; 2017 Sep; 9(9):CD008814. PubMed ID: 28901021
    [TBL] [Abstract][Full Text] [Related]  

  • 27. External Beam Radiation in Differentiated Thyroid Carcinoma.
    Billan S; Charas T
    Rambam Maimonides Med J; 2016 Jan; 7(1):. PubMed ID: 26886956
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prognostic value of adjuvant external beam radiotherapy for papillary thyroid cancer based on competitive risk model and propensity score matching.
    Zhou J; Wu C; Fan S; Zhao M
    Sci Rep; 2023 Apr; 13(1):6925. PubMed ID: 37117278
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Salvage high-dose-rate brachytherapy and external beam radiotherapy for isolated vaginal recurrences of endometrial cancer with no prior adjuvant therapy.
    Chapman CH; Maghsoudi K; Littell RD; Chen LM; Hsu IC
    Brachytherapy; 2017; 16(6):1152-1158. PubMed ID: 28802913
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Locally unresectable differentiated thyroid cancer: outcomes and perspectives.
    Lamartina L; Godbert Y; Nascimento C; Do Cao C; Hescot S; Borget I; Al Ghuzlan A; Hartl D; Hadoux J; Pottier E; Attard M; Berdelou A; Terroir M; Baudin E; Schlumberger M; Leboulleux S;
    Endocrine; 2020 Jul; 69(1):133-141. PubMed ID: 32147774
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Optimal cytoreduction followed by chemoradiation in stage IVB uterine serous carcinoma.
    McEachron J; Zhou N; Hastings V; Bennett M; Gorelick C; Kanis MJ; Lee YC
    Cancer Treat Res Commun; 2022; 33():100631. PubMed ID: 36096033
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Assessing the impact of brachytherapy boost and androgen deprivation therapy on survival outcomes for patients with unfavorable intermediate-risk prostate cancer patients treated with external beam radiotherapy.
    Andruska N; Agabalogun T; Fischer-Valuck BW; Brenneman RJ; Huang Y; Gay HA; Michalski JM; Carmona R; Baumann BC
    Brachytherapy; 2022; 21(5):617-625. PubMed ID: 35641370
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Survival Outcomes of Men with Lymph Node-positive Prostate Cancer After Radical Prostatectomy: A Comparative Analysis of Different Postoperative Management Strategies.
    Touijer KA; Karnes RJ; Passoni N; Sjoberg DD; Assel M; Fossati N; Gandaglia G; Eastham JA; Scardino PT; Vickers A; Cozzarini C; Montorsi F; Briganti A
    Eur Urol; 2018 Jun; 73(6):890-896. PubMed ID: 29042125
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The role of external beam radiation therapy in well-differentiated thyroid cancer.
    Hamilton SN; Tran E; Berthelet E; Wu J
    Expert Rev Anticancer Ther; 2017 Oct; 17(10):905-910. PubMed ID: 28750593
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Management of Retropharyngeal Lymph Node Metastases in Differentiated Thyroid Carcinoma.
    Harries V; McGill M; Tuttle RM; Shaha AR; Wong RJ; Shah JP; Patel SG; Ganly I
    Thyroid; 2020 May; 30(5):688-695. PubMed ID: 31910129
    [No Abstract]   [Full Text] [Related]  

  • 36. Metastasis after radical prostatectomy or external beam radiotherapy for patients with clinically localized prostate cancer: a comparison of clinical cohorts adjusted for case mix.
    Zelefsky MJ; Eastham JA; Cronin AM; Fuks Z; Zhang Z; Yamada Y; Vickers A; Scardino PT
    J Clin Oncol; 2010 Mar; 28(9):1508-13. PubMed ID: 20159826
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [CLINICAL OUTCOMES OF EXTERNAL-BEAM RADIOTHERAPY COMBINED WITH NEOADJUVANT ANDROGEN DEPRIVATION THERAPY FOR HIGH-RISK PROSTATE CANCER].
    Okada T; Takayama K; Kokubo M; Kono Y; Matsumoto K; Sumiyoshi T; Masuda N; Shiraishi Y; Negoro H; Utsunomiya N; Tsunemori H; Okubo K; Segawa T; Moroi S; Muguruma K; Kawakita M
    Nihon Hinyokika Gakkai Zasshi; 2016; 107(3):162-169. PubMed ID: 28740047
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long-term outcomes in oral cavity squamous cell carcinoma with adjuvant and salvage radiotherapy after surgery.
    Katsoulakis E; Leeman JE; Lok BH; Shi W; Zhang Z; Tsai JC; McBride SM; Sherman EJ; Cohen M; Wong R; Ganly I; Lee NY; Riaz N
    Laryngoscope; 2018 Nov; 128(11):2539-2545. PubMed ID: 29637571
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A long-term retrospective cohort-based risk-benefit analysis of augmenting total cumulative I-131 activity to 37GBq in differentiated thyroid cancer patients with skeletal metastases.
    Kanankulam Velliangiri S; Ballal S; Prasad Yadhav M; Tripathi M; Satapathy S; Bal C
    PLoS One; 2023; 18(11):e0294343. PubMed ID: 37963164
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Chemoradiotherapy for patients with locally advanced or unresectable extra-hepatic biliary cancer.
    Jethwa KR; Sannapaneni S; Mullikin TC; Harmsen WS; Petersen MM; Antharam P; Laughlin B; Mahipal A; Halfdanarson TR; Merrell KW; Neben-Wittich M; Sio TT; Haddock MG; Hallemeier CL
    J Gastrointest Oncol; 2020 Dec; 11(6):1408-1420. PubMed ID: 33457010
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.